Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $580.79)
- $580.79 P/E (TTM): 75.62X Cap: $202.93B
- View ISRG Profile
- View Questions on ISRG
-
AbbVie Inc. (ABBV $227.61)
- $227.61 P/E (TTM): 173.15X Cap: $400.87B
- View ABBV Profile
- View Questions on ABBV
-
Eli Lilly and Company (LLY $1,070.55)
- $1,070.55 P/E (TTM): 52.42X Cap: $1.01T
- View LLY Profile
- View Questions on LLY
-
Savaria Corporation (SIS $23.15)
- $23.15 P/E (TTM): 25.6X Cap: $1.57B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS
-
WELL Health Technologies Corp. (WELL $3.90)
- $3.90 Cap: $990M
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
-
DexCom Inc. (DXCM $67.38)
- $67.38 P/E (TTM): 36.91X Cap: $25.76B
- View DXCM Profile
- View Questions on DXCM
-
InMode Ltd. (INMD $14.55)
- $14.55 Cap: $998M
- View INMD Profile
- View Questions on INMD
-
Stryker Corp 1.000% Notes 2031 (SYK.31)
-
Lantheus Holdings Inc. (LNTH $68.39)
- $68.39 P/E (TTM): 27.36X Cap: $4.37B
- View LNTH Profile
- View Questions on LNTH
Q: I sold LNTH 30 days ago to harvest the tax loss. I am looking for one more name to fill my healthcare allotment. I currently own ABBV, ISRG, WELL and SIS. Which do you like best between LNTH, DXCM and INMD, which are three names that you have been highlighting over the past several months? I am looking for potentially higher growth and am willing to take on the additional risk. Any other name(s) would certainly be welcome.
Appreciate your insight.
Paul F.
Appreciate your insight.
Paul F.
Insiders
Share Information
SEC Filings
News and Media